Dishman Pharma forms JV with Japan's Azzurro

New Delhi, Mar 11 (UNI) Dishman Pharmaceuticals and Chemicals Ltd has formed a marketing joint venture in Japan with Azzurro Corporation to cater to the Japanese market.

The company will hold 85 per cent stake and Azzurro will have 15 per cent in this JV, called Dishman Japan Ltd (DJL).

DJL will market the products and services of Switzerland-based Dishman Carbogen-Amcis AG and of UK-based Synprotec DCR Ltd in Japan and South Korea.

Mr Takeshi Yokouchi will head DJL as Managing Director.

This is as an extremely important step since Japan Government has announced an open door policy for API's and intermediates and many Japanese companies are looking for suitable partners for contract research and API contract manufacturing on long-term basis, a company statement said.

UNI